The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments.
Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.
New positions: 2Exits: 3Increasing exposure: 2Reducing exposure: 2
+ MIRALTA NARVAL EUROPA, FI
Enters the position at 0.82% weight.
+ CAIXABANK MULTISALUD, FI
Enters the position at 0.29% weight.
− SANTANDER SOSTENIBLE CRECIMIENTO, FI
Leaves the position; it weighed 0.47%.
− SANTANDER SOSTENIBLE EVOLUCION, FI
Leaves the position; it weighed 0.99%.
− SANTANDER SOSTENIBLE ACCIONES, FI
Leaves the position; it weighed 2.53%.
Objective ratios
Not enough financial data on Yahoo Finance to calculate ratios for this company.
Disclaimer
This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.